X-65518409-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031206.7(LAS1L):c.1505G>A(p.Arg502His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,209,711 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R502P) has been classified as Uncertain significance.
Frequency
Consequence
NM_031206.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LAS1L | NM_031206.7 | c.1505G>A | p.Arg502His | missense_variant | 12/14 | ENST00000374811.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LAS1L | ENST00000374811.8 | c.1505G>A | p.Arg502His | missense_variant | 12/14 | 1 | NM_031206.7 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112964Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35122
GnomAD3 exomes AF: 0.0000329 AC: 6AN: 182111Hom.: 0 AF XY: 0.0000300 AC XY: 2AN XY: 66647
GnomAD4 exome AF: 0.0000128 AC: 14AN: 1096694Hom.: 0 Cov.: 32 AF XY: 0.0000166 AC XY: 6AN XY: 362148
GnomAD4 genome AF: 0.0000265 AC: 3AN: 113017Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35185
ClinVar
Submissions by phenotype
Wilson-Turner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LAS1L protein function. This variant has not been reported in the literature in individuals affected with LAS1L-related conditions. This variant is present in population databases (rs202068829, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 502 of the LAS1L protein (p.Arg502His). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at